Tokyo, July 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058642) titled 'Nationwide survey on treatment strategies for synchronous coexisting esophageal and head and neck cancers' on July 30.
Study Type:
Observational
Primary Sponsor:
Institute - Division of Esophageal Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research
Condition:
Condition - esophageal and head and neck cancers
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - We conducted a retrospective, multicenter collaborative study in Japan on synchronous coexisting esophageal cancer and head and neck cancer to clarify the current treatment strategies and outcomes and to explore optimal treatment methods for further improvement of outcomes.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Esophageal cancer: Patients with lesions mainly located in the cervical and thoracic esophagus and gastroesophageal junction. Histological type is not specified.
Head and neck cancer: Patients with lesions mainly located in the larynx and middle and lower pharynx. Histological type is limited to squamous cell carcinoma.
Key exclusion criteria - Head and neck cancer: Patients with lesions mainly located in the lips and oral cavity, nasal cavity and paranasal sinuses, major salivary glands, and nasopharynx. Also, patients with non-squamous cell carcinoma of the larynx and middle and lower pharynx.Cases that refused participation by opting out
Target Size - 752
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 07 Month 02 Day
Anticipated trial start date - 2025 Year 08 Month 01 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067062
Disclaimer: Curated by HT Syndication.
